Neuland Labs gets USFDA EIR for Pashamylaram Manufacturing Facility
Hyderabad: Neuland Labs has received an Establishment Inspection Report (EIR) from the U.S.FDA for its manufacturing facility located at Pashamylaram, Hyderabad.
"The facility was inspected from 3 rd to 7th February 2020. The inspection has now been closed by the U.S. FDA," the company confirmed in a BSE filing
Neuland Laboratories Limited was established in 1984 and is a publicly listed company headquartered in Hyderabad, India.
The company produces active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry's chemistry needs.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.